Canada · Health Canada Drug Product Database
NEOSURF
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 77404
- DIN
- 02288621
- Form
- Suspension
- Company as listed by source
- CIPLA LTD
- Source status
- Cancelled (Unreturned Annual) (2026-01-15)
- Source last updated
- 2026-01-15
Source-listed ingredients
- PHOSPHOLIPID — 27 MG — per 1 ML
- SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C — 500 MCG — per 1 ML
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →